Medication info

Yudron Injection (Evandron Sodium Dihydrate)

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Ibandronate Sodium Monohydrate›3.375mg / 1 prefilled syringe
Manufacturer / importer
YouYoung Pharmaceutical Co., Ltd.
Appearance
It is an injection in a colorless and transparent solution contained in a colorless and transparent glass prefilled syringe, with a single-use syringe needle attached.
Packaging
3ml x 1 vial
Approval status
Active

MFDS item code 201907758 · Notified 2019.11.05 · Insurance code 648204431

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who receives it
Adults · Children
Adult administration
Administer 3mg by intravenous injection over 15 - 30 seconds once every 3 months. Patients should take calcium and vitamin D supplements. If a scheduled dose is missed, administer the injection as soon as possible and then continue regular dosing at 3-month intervals from that date. Patients with hepatic impairment No dosage adjustment is required. Patients with renal impairment No dosage adjustment is required for patients with mild or moderate renal impairment whose serum creatinine is 200 µmol/L(2.3mg/dL) or lower, or whose creatinine clearance is 30ml/min or higher. Use of this drug is not recommended in patients whose serum creatinine exceeds 200 µmol/L(2.3mg/dL) or whose creatinine clearance is less than 30ml/min, because clinical experience is insufficient. Older adults No dosage adjustment is required.
Child administration
Efficacy and safety have not been studied in children 18 years of age or younger.

Ingredients

Manufacturer
YouYoung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in postmenopausal women. It helps strengthen bones and increase bone density to reduce the risk of fractures. It assists in preventing bone loss due to menopause to maintain healthy bones. It also has the effect of alleviating pain and discomfort caused by osteoporosis. Therefore, it is used for the treatment of osteoporosis in postmenopausal women.

How it is given

Adult administration

Administer 3mg by intravenous injection over 15 - 30 seconds once every 3 months. Patients should take calcium and vitamin D supplements. If a scheduled dose is missed, administer the injection as soon as possible and then continue regular dosing at 3-month intervals from that date. Patients with hepatic impairment No dosage adjustment is required. Patients with renal impairment No dosage adjustment is required for patients with mild or moderate renal impairment whose serum creatinine is 200 µmol/L(2.3mg/dL) or lower, or whose creatinine clearance is 30ml/min or higher. Use of this drug is not recommended in patients whose serum creatinine exceeds 200 µmol/L(2.3mg/dL) or whose creatinine clearance is less than 30ml/min, because clinical experience is insufficient. Older adults No dosage adjustment is required.

Child administration

Efficacy and safety have not been studied in children 18 years of age or younger.

Precautions

This medication must only be administered intravenously, and caution is necessary as administering it into an artery or around the injection site can cause tissue damage. Patients with allergies to this drug or its components, or with untreated hypocalcemia, should not use this medication. During use, gastrointestinal symptoms such as gastritis, diarrhea, abdominal pain, indigestion, nausea, and constipation, as well as musculoskeletal pain, joint pain, and muscle pain may occur. Additionally, flu-like symptoms such as fever, chills, fatigue, and muscle aches may temporarily appear at the start of administration. Rarely, severe allergic reactions such as skin rash, headache, vasculitis, and anaphylaxis may occur, so symptoms should be reported to medical personnel immediately. This medication may temporarily lower calcium levels, so patients must treat hypocalcemia or bone and mineral metabolism disorders before administration, and it is important to ingest sufficient calcium and vitamin D. Patients requiring dental treatment should undergo an oral examination before administration of this medication, and it is advisable to avoid excessive dental procedures during treatment. This medication may increase the risk of rare side effects such as osteonecrosis of the jaw and external auditory canal, as well as atypical fractures of the femur and other bones, so if there is pain in the legs or pelvis, medical personnel should be consulted immediately. It is recommended that pregnant or breastfeeding women do not use this medication. In case of overdose, careful monitoring of kidney and liver functions is required, and appropriate treatment is necessary if hypocalcemia occurs. This medication should not be mixed with calcium-containing solutions or other medications and must be administered intravenously. Keep out of reach of children, and do not reuse used syringes and needles; dispose of them safely.

Side effects

  • Gastritis
  • diarrhea
  • abdominal pain
  • indigestion
  • nausea
  • constipation
  • musculoskeletal pain
  • joint pain
  • muscle pain
  • influenza-like illness
Show 28 more
  • fatigue
  • headache
  • rash
  • bone pain
  • weakness
  • injection site reaction
  • phlebitis
  • thrombophlebitis
  • hypersensitivity reaction
  • angioedema
  • facial swelling
  • edema
  • urticaria
  • uveitis
  • episcleritis
  • scleritis
  • anaphylactic reaction
  • shock
  • asthma exacerbation
  • allergic reaction
  • Stevens-Johnson syndrome
  • erythema multiforme
  • vesicular dermatitis
  • atypical subtrochanteric fracture
  • intertrochanteric femoral fracture
  • external auditory canal osteonecrosis
  • acute kidney failure
  • sensory loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is best to maintain a storage temperature between 1 degrees and 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

It is an injection in a colorless and transparent solution contained in a colorless and transparent glass prefilled syringe, with a single-use syringe needle attached.

Package unit

3ml x 1 vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.